Table 3 Efficacy of diverse hormone receptor and androgen receptor status
Characteristics | tpCR, n(%) | Non-tpCR, n(%) | χ2 | P | bpCR, n(%) | Non-bpCR, n(%) | χ2 | P |
|---|---|---|---|---|---|---|---|---|
ER | ||||||||
 Positive (n = 63) | 23(33.82) | 40(57.14) | 7.560 | 0.006 | 29(38.67) | 34(53.97) | 3.231 | 0.072 |
 Negative (n = 75) | 45(66.18) | 30(42.86) | 46(61.33) | 29(46.03) | ||||
PR | ||||||||
 Positive (n = 54) | 18(26.47) | 36(51.43) | 9.021 | 0.003 | 22(29.33) | 32(50.79) | 6.620 | 0.010 |
 Negative (n = 84) | 50(73.53) | 34(48.57) | 53(70.67) | 31(49.21) | ||||
HR | ||||||||
 ER and/or PR positive (n = 69) | 26(38.24) | 43(61.43) | 7.422 | 0.006 | 32(42.67) | 37(58.73) | 3.534 | 0.060 |
 ER and PR negative (n = 69) | 42(61.76) | 27(38.57) | 43(57.33) | 26(41.27) | ||||
AR | ||||||||
 Positive (n = 117) | 53(77.94) | 64(91.43) | 4.863 | 0.027 | 59(78.67) | 58(92.06) | 4.763 | 0.029 |
 Negative (n = 21) | 15(22.06) | 6(8.57) | 16(21.33) | 5(7.94) | ||||